CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 81 enrolled
Drug / intervention
Model SN60WF +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00758745
NCT00758745N/ACompleted

Randomized Contralateral Clinical Trial With Single-piece (SN60WF) vs. Three Piece (MA60AC) AcrySof Intraocular Lenses (IOLs) on Development of Posterior Chamber Opacification (PCO).

Alcon Research·interventional·Posted Sep 25, 2008·Updated Aug 19, 2014

In Brief

A clinical study evaluating Model SN60WF and Model MA60AC for Cataract. Completed, enrolled 81 participants across 1 site.

Detailed Summary

Randomized contralateral clinical trial with single piece (Model SN60WF) vs. three piece (Model MA60AC) AcrySof Intraocular Lenses (IOLs) on development of Posterior Chamber Opacifiation (PCO).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 25, 2008
Enrollment StartJan 1, 2006
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 17.8 years ago

Interventions

Model SN60WFdevice

Implantation with the AcrySof Model SN60WF Single-piece intraocular lens (IOL) following cataract removal.

Model MA60ACdevice

Implantation with the AcrySof Model MA60AC multi-piece intraocular lens (IOL) following cataract surgery.